The U.S. Food and Drug Administration on Monday approved a second nasal spray for reversing an opioid overdose. To be sold as ...
"On the heels of the FDA's recent approval of the first over-the-counter opioid reversal agent [Narcan], the availability of nalmefene nasal spray places a new prescription opioid reversal option ...
“We’re not suffering from a naloxone shortage where we need to use an alternative,” he said. “We have plenty of it and it works perfectly well.” The FDA approval comes as drug overdose ...
The FDA approved a new nasal spray to reverse the effects of an opioid overdose. Ready why the application for this drug was ...
Signage is seen outside of the Food and Drug Administration (FDA) headquarters ... on Monday approved Opiant Pharmaceuticals Inc's nasal spray for reversing opioid-related overdoses, expanding ...
The U.S. Food and Drug Administration has approved Brixadi (buprenorphine) extended-release injection to treat ...
After a more than 4-year battle, Plymouth Meeting biotechnology firm Braeburn Inc. has received FDA approval for its opioid ...
“We’re not suffering from a naloxone shortage where we need to use an alternative,” he said. “We have plenty of it and it works perfectly well.” The FDA approval comes as drug overdose ...
“We’re not suffering from a naloxone shortage where we need to use an alternative,” he said. “We have plenty of it and it works perfectly well.” The FDA approval comes as drug overdose ...
The Food and Drug Administration (FDA) approved a prescription nasal spray this week that can reverse opioid overdoses. Opvee is an almefene hydrochloride nasal spray that is the first of its kind ...
The Food and Drug Administration on Monday approved Opvee, the first prescription nasal spray for opioid overdoses using nalmefene hydrochloride.
The Food and Drug Administration (FDA) approved a prescription nasal spray this week that can reverse opioid overdoses. Opvee is an almefene hydrochloride nasal spray that is the first of its kind to ...
